DRY EYE DISEASE (DED)

This study compares two treatments for dry eye disease: SYSTANE PRO eye drops and MIEBO eye drops. About 260 adults with dry eye will use one of the two treatments for one month. The goal is to see if SYSTANE PRO works as well as MIEBO at relieving dry eye symptoms.

This study tests whether licaminlimab eye drops can safely reduce eye discomfort in people with dry eye disease who have a specific gene (TNFR1). About 160 adults will receive either the drug or a placebo (vehicle) for 29 days. The main goal is to see if the drops improve overall…

This study tests a new preservative-free eye drop for people with dry eye disease. The goal is to see if it improves eye comfort and quality of life over 6 months. About 30 adults who have had dry eyes for at least 3 months will use the drops daily and report their symptoms.

This study tests whether a standard cosmetic treatment for eye wrinkles, called Tixel, can also improve symptoms and signs of dry eye disease. About 36 adults with mild to moderate wrinkles and dry eyes will receive either real Tixel or a sham (fake) treatment. Researchers will t…

This study tests a new eye drop (FBV_01) that combines an extra ingredient with hyaluronic acid to see if it works better than hyaluronic acid alone for people with moderate-to-severe dry eye. About 74 adults will use the drops four times a day for one month. The goal is to find …

This study tests a gel placed in the tear ducts before cataract surgery to see if it helps dry eyes. About 60 adults with dry eye disease will receive the gel and be followed for 3 months. The main goal is to measure tear film stability using a non-invasive test.

This study tests whether taking stingless bee (Kelulut) honey daily for three months can reduce inflammation and improve eye health in 60 people aged 15 to 40 with juvenile open-angle glaucoma. Participants either take honey or no extra treatment. Researchers will measure changes…

This study looks at whether a special ingredient called trehalose, found in some artificial tears, can improve the eye's natural barrier in people with moderate-to-severe dry eye. About 30 adults will use the eye drops for one month. Researchers will measure how well the cornea k…

This study looks at whether a new cyclosporin eye drop (Vevizye®) can reduce inflammation and dryness in people with moderate to severe dry eye disease who still have symptoms after using artificial tears. About 25 adults with chronic dry eye and visible eye redness will use the …

This study looks at how a common anti-inflammatory eye drop (cyclosporin A) changes immune cells on the eye's surface in people with dry eye disease. Researchers will use a special microscope to watch these cells move and collect tear samples to measure inflammation. The goal is …

This study looks at proteins in tears to help diagnose and manage dry eye disease. Researchers will test a special treatment device and see how it changes tear proteins. The study involves 75 people with dry eye and aims to improve understanding and care for this condition.